STAT3 mediates resistance to anoikis and promotes invasiveness of nasopharyngeal cancer cells

Lin,Chien-Hung; Chiang,Ming-Chang; Chen,Yann-Jang

doi:10.3892/ijmm.2017.3151

STAT3 mediates resistance to anoikis and promotes invasiveness of nasopharyngeal cancer cells

Authors:
- Chien-Hung Lin
- Ming-Chang Chiang
- Yann-Jang Chen
View Affiliations

Affiliations: Institute of Clinical Medicine, National Yang-Ming University, Taipei 112, Taiwan, R.O.C., Department of Life Science, College of Science and Engineering, Fu Jen Catholic University, New Taipei City 24205, Taiwan, R.O.C.
Published online on: September 25, 2017 https://doi.org/10.3892/ijmm.2017.3151
Pages: 1549-1556

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Nasopharyngeal carcinoma (NPC), a tumor arising from the epithelial cells of the nasopharynx, is endemic in Southeast Asia and Taiwan. The prognosis of NPC patients with local recurrence and metastasis is poor. Resistance to anoikis is a primary characteristic of tumor cells that metastasize. However, the mechanism through which NPC cells resist anoikis and are able to metastasize has not been fully elucidated. In the present study, the acquisition of anoikis resistance was analyzed in the TW01 and TW06 human NPC cell lines growing under anchorage-independent conditions. A considerable number of TW01 and TW06 cells was found to be resistant to anoikis and exhibited a higher capability of migration and invasion. These anoikis-resistant NPC cells exhibited significantly increased expression of signal transducer and activation of transcription 3 (Stat3) compared with adherent cells. Furthermore, blockade of STAT3 expression by STAT3 inhibitors or STAT3 silencing significant increased anoikis in anoikis-resistant NPC cells. Moreover, silencing STAT3 not only reduced the capacity of NPC cells to resist anoikis, but also reversed their invasive properties. The expression of epithelial‑to-mesenchymal transition‑related proteins and CD44 was also significantly decreased following STAT3 knockdown. The results of the present study established that STAT3 mediates anoikis resistance, with enhanced cell migration and invasion of NPC cells, and that activation of STAT3 may increase metastatic capacity, indicating the crucial role of STAT3 in conferring anoikis resistance and enhanced invasive properties to NPC cells.

View Figures

View References

1	Yeh SA, Tang Y, Lui CC, Huang YJ and Huang EY: Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone. Int J Radiat Oncol Biol Phys. 62:672–679. 2005. View Article : Google Scholar : PubMed/NCBI
2	Sun JD, Chen CZ, Chen JZ, Li DS, Chen ZJ, Zhou MZ and Li DR: Long term outcomes and prognostic factors of n0 stage nasopharyngeal carcinoma: A single institutional experience with 610 patients. Asian Pac J Cancer Prev. 13:2101–2107. 2012. View Article : Google Scholar : PubMed/NCBI
3	Nagaprashantha LD, Vatsyayan R, Lelsani PC, Awasthi S and Singhal SS: The sensors and regulators of cell-matrix surveillance in anoikis resistance of tumors. Int J Cancer. 128:743–752. 2011. View Article : Google Scholar
4	Zhong X and Rescorla FJ: Cell surface adhesion molecules and adhesion-initiated signaling: Understanding of anoikis resistance mechanisms and therapeutic opportunities. Cell Signal. 24:393–401. 2012. View Article : Google Scholar
5	Morimoto-Tomita M, Ohashi Y, Matsubara A, Tsuiji M and Irimura T: Mouse colon carcinoma cells established for high incidence of experimental hepatic metastasis exhibit accelerated and anchorage-independent growth. Clin Exp Metastasis. 22:513–521. 2005. View Article : Google Scholar : PubMed/NCBI
6	Egwuagu CE: STAT3 in CD4⁺ T helper cell differentiation and inflammatory diseases. Cytokine. 47:149–156. 2009. View Article : Google Scholar : PubMed/NCBI
7	Konnikova L, Simeone MC, Kruger MM, Kotecki M and Cochran BH: Signal transducer and activator of transcription 3 (STAT3) regulates human telomerase reverse transcriptase (hTERT) expression in human cancer and primary cells. Cancer Res. 65:6516–6520. 2005. View Article : Google Scholar : PubMed/NCBI
8	Chen Z and Han ZC: STAT3: A critical transcription activator in angiogenesis. Med Res Rev. 28:185–200. 2008. View Article : Google Scholar
9	Peyser ND and Grandis JR: Critical analysis of the potential for targeting STAT3 in human malignancy. Onco Targets Ther. 6:999–1010. 2013.PubMed/NCBI
10	Banerjee K and Resat H: Constitutive activation of STAT3 in breast cancer cells: A review. Int J Cancer. 138:2570–2578. 2016. View Article : Google Scholar :
11	Weerasinghe P, Garcia GE, Zhu Q, Yuan P, Feng L, Mao L and Jing N: Inhibition of Stat3 activation and tumor growth suppression of non-small cell lung cancer by G-quartet oligonucleotides. Int J Oncol. 31:129–136. 2007.PubMed/NCBI
12	Lui VW, Wong EY, Ho Y, Hong B, Wong SC, Tao Q, Choi GC, Au TC, Ho K, Yau DM, et al: STAT3 activation contributes directly to Epstein-Barr virus-mediated invasiveness of nasopharyngeal cancer cells in vitro. Int J Cancer. 125:1884–1893. 2009. View Article : Google Scholar : PubMed/NCBI
13	Wang Z, Luo F, Li L, Yang L, Hu D, Ma X, Lu Z, Sun L and Cao Y: STAT3 activation induced by Epstein-Barr virus latent membrane protein1 causes vascular endothelial growth factor expression and cellular invasiveness via JAK3 And ERK signaling. Eur J Cancer. 46:2996–3006. 2010. View Article : Google Scholar : PubMed/NCBI
14	Bensouda Y, Kaikani W, Ahbeddou N, Rahhali R, Jabri M, Mrabti H, Boussen H and Errihani H: Treatment for metastatic nasopharyngeal carcinoma. Eur Ann Otorhinolaryngol Head Neck Dis. 128:79–85. 2011. View Article : Google Scholar
15	Pan CC, Lu J, Yu JR, Chen P, Li W, Huang ZL, Zhao M, Huang ZM, Xia YF, Wu YH, et al: Challenges in the modification of the M1 stage of the TNM staging system for nasopharyngeal carcinoma: A study of 1027 cases and review of the literature. Exp Ther Med. 4:334–338. 2012. View Article : Google Scholar : PubMed/NCBI
16	Tan K, Goldstein D, Crowe P and Yang JL: Uncovering a key to the process of metastasis in human cancers: A review of critical regulators of anoikis. J Cancer Res Clin Oncol. 139:1795–1805. 2013. View Article : Google Scholar : PubMed/NCBI
17	Paoli P, Giannoni E and Chiarugi P: Anoikis molecular pathways and its role in cancer progression. Biochim Biophys Acta. 1833:3481–3498. 2013. View Article : Google Scholar : PubMed/NCBI
18	Raptis L, Arulanandam R, Vultur A, Geletu M, Chevalier S and Feracci H: Beyond structure, to survival: Activation of Stat3 by cadherin engagement. Biochem Cell Biol. 87:835–843. 2009. View Article : Google Scholar : PubMed/NCBI
19	Fitzgerald JS, Poehlmann TG, Schleussner E and Markert UR: Trophoblast invasion: The role of intracellular cytokine signalling via signal transducer and activator of transcription 3 (STAT3). Hum Reprod Update. 14:335–344. 2008. View Article : Google Scholar : PubMed/NCBI
20	Zhang W, Zong CS, Hermanto U, Lopez-Bergami P, Ronai Z and Wang LH: RACK1 recruits STAT3 specifically to insulin and insulin-like growth factor 1 receptors for activation, which is important for regulating anchorage-independent growth. Mol Cell Biol. 26:413–424. 2006. View Article : Google Scholar :
21	Cheng HL, Su SJ, Huang LW, Hsieh BS, Hu YC, Hung TC and Chang KL: Arecoline induces HA22T/VGH hepatoma cells to undergo anoikis - involvement of STAT3 and RhoA activation. Mol Cancer. 9:1262010. View Article : Google Scholar : PubMed/NCBI
22	Hu Y, Chen H, Duan C, Liu D, Qian L, Yang Z, Guo L, Song L, Yu M, Hu M, et al: Deficiency of Erbin induces resistance of cervical cancer cells to anoikis in a STAT3-dependent manner. Oncogenesis. 2:e522013. View Article : Google Scholar : PubMed/NCBI
23	Gao Y, Ruan B, Liu W, Wang J, Yang X, Zhang Z, Li X, Duan J, Zhang F, Ding R, et al: Knockdown of CD44 inhibits the invasion and metastasis of hepatocellular carcinoma both in vitro and in vivo by reversing epithelial-mesenchymal transition. Oncotarget. 6:7828–7837. 2015. View Article : Google Scholar : PubMed/NCBI
24	Lin CH, Hung PH and Chen YJ: CD44 is associated with the aggressive phenotype of nasopharyngeal carcinoma through redox regulation. Int J Mol Sci. 14:13266–13281. 2013. View Article : Google Scholar : PubMed/NCBI
25	Luo W and Yao K: Molecular characterization and clinical implications of spindle cells in nasopharyngeal carcinoma: A novel molecule-morphology model of tumor progression proposed. PLoS One. 8:e831352013. View Article : Google Scholar : PubMed/NCBI
26	Lin JC, Liao SK, Lee EH, Hung MS, Sayion Y, Chen HC, Kang CC, Huang LS and Cherng JM: Molecular events associated with epithelial to mesenchymal transition of nasopharyngeal carcinoma cells in the absence of Epstein-Barr virus genome. J Biomed Sci. 16:1052009. View Article : Google Scholar : PubMed/NCBI
27	Kamran MZ, Patil P and Gude RP: Role of STAT3 in cancer metastasis and translational advances. BioMed Res Int. 2013:4218212013. View Article : Google Scholar : PubMed/NCBI
28	Devarajan E and Huang S: STAT3 as a central regulator of tumor metastases. Curr Mol Med. 9:626–633. 2009. View Article : Google Scholar : PubMed/NCBI